Cabot Corp Files DEF 14A for Executive Compensation

Ticker: CBT · Form: DEF 14A · Filed: Jan 24, 2025 · CIK: 16040

Sentiment: neutral

Topics: executive-compensation, corporate-governance, annual-filing

Related Tickers: CBT

TL;DR

Cabot Corp (CBT) DEF 14A out: Executive pay details for FY24, shareholder info.

AI Summary

Cabot Corporation (NYSE: CBT) filed its DEF 14A on January 24, 2025, detailing executive compensation and corporate governance matters for the fiscal year ending September 30, 2024. The filing includes information on equity awards, performance-based compensation, and other financial metrics relevant to its shareholders. Key financial periods covered include fiscal years 2021-2023, with specific data points on equity awards and their valuations.

Why It Matters

This filing provides shareholders with crucial information regarding how executive compensation is structured and how it aligns with the company's performance, impacting investor decisions.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) detailing executive compensation and corporate governance, not indicating new or unusual risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, like the one from Cabot Corporation, is used to solicit shareholder votes on important matters, typically including the election of directors and executive compensation.

When was Cabot Corporation's DEF 14A filed?

Cabot Corporation's DEF 14A was filed on January 24, 2025.

What fiscal year does this DEF 14A primarily relate to?

While it covers historical data, the filing pertains to the fiscal year ending September 30, 2024, and includes data from fiscal years 2021-2023.

What type of financial information is detailed in this filing?

The filing details executive compensation, including equity awards, performance-based compensation, and related financial metrics.

Where is Cabot Corporation headquartered?

Cabot Corporation is headquartered at Two Seaport Lane, Suite 1400, Boston, MA 02210.

Filing Stats: 4,750 words · 19 min read · ~16 pages · Grade level 13 · Accepted 2025-01-24 11:52:03

Filing Documents

Executive Compensation

Executive Compensation 33 Compensation Committee Report 33 Compensation Discussion and Analysis 33 Summary Compensation Table 53 Grant of Plan-Based Awards Table 55 Outstanding Equity Awards at Fiscal Year-End Table 57 Option Exercises and Stock Vested Table 58 Pension Benefits 58 Deferred Compensation 59 Potential Payments Upon Termination or Change in Control 61 CEO Pay Ratio 66 Pay Versus Performance 67 Proposal 2 — Advisory Approval of Executive Compensation 71 Proposal 3 — Approval of the Cabot Corporation 2025 Long-Term Incentive Plan 72 Audit Committee Matters 79 Audit Committee Report 79 Audit Fees 80 Audit Committee Pre-Approval Policy 80 Table of Contents 2025 PROXY STATEMENT Table of Contents (continued) Proposal 4 — Ratification of Appointment of Independent Registered Public Accounting Firm 81 Other Information 82 Equity Compensation Plan Information 82 Future Stockholder Proposals and Director Nominations 82 Available Information 83 Solicitation of Proxies 83 Miscellaneous 83 Appendix A — Cabot Corporation 2025 Long-Term Incentive Plan A-1 Appendix B — Non-GAAP Measures B-1 Table of Contents 2025 PROXY STATEMENT About the Annual Meeting Cabot Corporation Two Seaport Lane, Suite 1400 Boston, Massachusetts 02210-2019 Proxy Statement References to "the Company", "Cabot", "we", "us", and "our" in this proxy statement mean Cabot Corporation. About the Annual Meeting Who is soliciting my vote? The Board of Directors of Cabot Corporation is soliciting your vote at the 2025 Annual Meeting of Stockholders (the "2025 Annual Meeting" or the "meeting"). What am I voting on? You are voting on: Proposal 1: Election of Michael M. Morrow, Thierry Vanlancker, Michelle E. Williams, and Frank A. Wilson to the class of directors whose term expires in 2028 ( see page 19 ); Proposal 2: Advisory approval of our executive compensation (

Forward-Looking Statements

Forward-Looking Statements This proxy statement may contain "forward-looking statements" under the federal securities laws. These forward-looking statements include information concerning our possible or assumed future business strategies, potential growth opportunities, potential operating performance improvements, and expectations related to governance and management. Generally, the words "believe," "expect," "plan," "intend," "anticipate," "estimate," "predict," "potential," "continue," "may," "should" or the negative of these terms or similar expressions that do not relate to historical facts are intended to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, potentially inaccurate assumptions, and other factors, some of which are beyond our control or difficult to predict. If known or unknown risks materialize, our actual results could differ materially from past results and from those expressed in the forward-looking statements. Investors are therefore cautioned not to place undue reliance on forward-looking statements. Important factors that could cause our results to differ materially from those expressed or implied in the forward-looking statements include, but are not limited to, industry capacity utilization and competition from other specialty chemical companies; safety, health and environmental requirements and related constraints imposed on our business; regulatory and financial risks related to climate change developments; volatility in the price and availability of energy and raw materials, including with respect to the Russian invasion of Ukraine and the U.S.-China trade relationship; a significant adverse change in a customer relationship or the failure of a customer to perform its obligations under agreements with us; failure to achieve growth expectations from new products, applications and technology developments; failure to realize benefits from ac

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing